Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Infliximab

Rawish Fatima  1 , Khaled Bittar  2 , Muhammad Aziz  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Infliximab

Rawish Fatima et al.
Free Books & Documents

Excerpt

This activity discusses the mechanism of action and clinical applications of infliximab, a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α). This FDA-approved therapy addresses inflammatory conditions, including Crohn disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and severe plaque psoriasis. The program details infliximab's pharmacokinetics, dosing considerations, contraindications, and monitoring protocols, offering healthcare professionals a comprehensive understanding essential for personalized patient care. Highlighting the significance of an interprofessional approach, this initiative emphasizes the collaborative effort necessary to navigate infliximab therapy effectively. This educational endeavor aims to optimize treatment strategies, mitigate adverse events, and enhance clinical outcomes across diverse patient populations by empowering healthcare professionals with evidence-based insights.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Rawish Fatima declares no relevant financial relationships with ineligible companies.

Disclosure: Khaled Bittar declares no relevant financial relationships with ineligible companies.

Disclosure: Muhammad Aziz declares no relevant financial relationships with ineligible companies.

References

    1. Liu Y, Liu S, Liu L, Gong X, Liu J, Sun L, Liu X, Wu L, Chen L, Wang L, Luo L, Lin J, Tie N, Jiang Z, Wu J, Lu F, Sun H, Li X, Yang N, Chai K, Wei H, Da Z, Zhao C, Dai L, Wang Y, Shi G, Zhang Z, Song H, Guo Q, Liu YC, Li Z. Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study. Rheumatol Ther. 2022 Feb;9(1):175-189. - PMC - PubMed
    1. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet. 1999 Dec 04;354(9194):1932-9. - PubMed
    1. Lahad A, Weiss B. Current therapy of pediatric Crohn's disease. World J Gastrointest Pathophysiol. 2015 May 15;6(2):33-42. - PMC - PubMed
    1. Pola S, Patel D, Ramamoorthy S, McLemore E, Fahmy M, Rivera-Nieves J, Chang JT, Evans E, Docherty M, Talamini M, Sandborn WJ. Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1315-1325.e4. - PMC - PubMed
    1. Alpsoy E, Leccese P, Emmi G, Ohno S. Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach. Front Med (Lausanne) 2021;8:624795. - PMC - PubMed

Publication types

LinkOut - more resources